Literature DB >> 33861389

Association between gastroesophageal reflux disease and colorectal cancer risk: a population-based cohort study.

Je-Ming Hu1,2, Jia-Jheng Wu3, Chih-Hsiung Hsu3,4, Yong-Chen Chen5,6, Yu-Feng Tian7,8, Pi-Kai Chang1,2, Chao-Yang Chen2, Yu-Ching Chou3, Chien-An Sun9,10.   

Abstract

PURPOSE: Several studies have investigated the association between gastroesophageal reflux disease (GERD) and colorectal cancer (CRC) risk, but the presented scientific results are highly debatable. This study examined the longitudinal association between GERD and CRC in an Asian population.
METHODS: A retrospective cohort study was performed using the National Health Insurance Research Database of Taiwan. The study cohort comprised 45,828 individuals with newly diagnosed GERD (the GERD cohort) and 229,140 age, sex, and date of enrollment-matched patients without GERD (the comparison cohort) from 2000 to 2006. The primary outcome was the incidence of CRC. To estimate the effect of GERD on the risk of CRC, the Cox proportional hazards model was fitted to estimate hazard ratios (HRs) and 95% confidence intervals (CIs).
RESULTS: There were 785 newly diagnosed CRC patients in the 45,828 patients with GERD. Relatively, there were 2375 incident CRC cases in 229,140 patients without GERD. The incidence rate of CRC for the GERD cohort (17.60 per 10,000 person-years) was significantly higher than the corresponding incidence rate for the comparison cohort (10.22 per 10,000 person-years). After adjustment for confounders, GERD was associated with a significantly increased risk of CRC (adjusted HR,1.76; 95% CI, 1.62-2.90). Of note, a significant association between GERD and CRC risk was evident in both genders.
CONCLUSIONS: In conclusion, this nationwide population-based cohort study supports the hypothesis that GERD was associated with a significantly increased risk of CRC. Our findings warrant still further investigation of the underlying mechanisms related to carcinogenic effect of GERD on colorectal carcinoma.

Entities:  

Keywords:  Colorectal cancer; Gastroesophageal reflux disease; National Health Insurance Research Database; Retrospective cohort study

Year:  2021        PMID: 33861389     DOI: 10.1007/s00384-021-03873-2

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  23 in total

1.  Overexpression of glycine-extended gastrin in transgenic mice results in increased colonic proliferation.

Authors:  T J Koh; G J Dockray; A Varro; R J Cahill; C A Dangler; J G Fox; T C Wang
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

2.  Cancer statistics, 2020.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2020-01-08       Impact factor: 508.702

3.  Hypergastrinemia promotes adenoma progression in the APC(Min-/+) mouse model of familial adenomatous polyposis.

Authors:  S A Watson; A M Smith
Journal:  Cancer Res       Date:  2001-01-15       Impact factor: 12.701

4.  Global cancer transitions according to the Human Development Index (2008-2030): a population-based study.

Authors:  Freddie Bray; Ahmedin Jemal; Nathan Grey; Jacques Ferlay; David Forman
Journal:  Lancet Oncol       Date:  2012-06-01       Impact factor: 41.316

5.  Epidemiology of gastroesophageal reflux disease in Asia: a systematic review.

Authors:  Hye-Kyung Jung
Journal:  J Neurogastroenterol Motil       Date:  2011-01-26       Impact factor: 4.924

6.  Barrett's metaplasia and colonic neoplasms: a significant association in a 203,534-patient study.

Authors:  Amnon Sonnenberg; Robert M Genta
Journal:  Dig Dis Sci       Date:  2013-01-31       Impact factor: 3.199

7.  Correlation of Barrett's esophagus with colorectal polyps in Japanese patients: A retrospective chart review.

Authors:  Hironobu Takedomi; Nanae Tsuruoka; Ayako Takamori; Koichi Miyahara; Kohei Yamanouchi; Takuya Shimamura; Yo Fujimoto; Takahiro Noda; Takuya Matsunaga; Yoshimichi Takara; Furitsu Shimada; Hidenori Hidaka; Hiroyoshi Endo; Keizo Anzai; Kazuma Fujimoto
Journal:  J Gastroenterol Hepatol       Date:  2019-02-19       Impact factor: 4.029

8.  Pentagastrin stimulates in vitro growth of normal and malignant human colon epithelial cells.

Authors:  K R Sirinek; B A Levine; M P Moyer
Journal:  Am J Surg       Date:  1985-01       Impact factor: 2.565

9.  Barrett's oesophagus is not a risk factor for colonic neoplasia: a case-control study.

Authors:  R Laitakari; P Laippala; J Isolauri
Journal:  Ann Med       Date:  1995-08       Impact factor: 4.709

10.  Risk of colorectal cancer in patients with Barrett's esophagus: A Dutch population-based study.

Authors:  Pieter J F de Jonge; Mark van Blankenstein; Caspar W N Looman; Mariël K Casparie; Gerrit A Meijer; Ernst J Kuipers
Journal:  Am J Gastroenterol       Date:  2009-09-01       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.